# | Company | Symbol | Weight | Price | Chg | % Chg |
---|---|---|---|---|---|---|
1 | Crispr Therapeutics Ag | CRSP | 10.29% | ![]() |
2.75 | (5.01%) |
2 | Tempus Ai Inc | TEM | 8.62% | ![]() |
0.13 | (0.22%) |
3 | Twist Bioscience Corp | TWST | 7.27% | ![]() |
1.02 | (2.74%) |
4 | Guardant Health Inc | GH | 6.39% | ![]() |
0.23 | (0.46%) |
5 | Recursion Pharmaceuticals-A | RXRX | 5.51% | ![]() |
0.26 | (4.78%) |
6 | Natera Inc | NTRA | 5.10% | ![]() |
2.59 | (1.63%) |
7 | Personalis Inc | PSNL | 4.54% | ![]() |
-0.03 | (-0.42%) |
8 | Adaptive Biotechnologies | ADPT | 4.34% | ![]() |
0.01 | (0.10%) |
9 | Schrodinger Inc | SDGR | 3.86% | ![]() |
0.16 | (0.77%) |
10 | Beam Therapeutics Inc | BEAM | 3.79% | ![]() |
0.97 | (4.77%) |
11 | 10x Genomics Inc-Class A | TXG | 3.77% | ![]() |
-0.01 | (-0.10%) |
12 | Caredx Inc | CDNA | 3.70% | ![]() |
0.66 | (3.43%) |
13 | Ionis Pharmaceuticals Inc | IONS | 3.44% | ![]() |
0.33 | (0.80%) |
14 | Veracyte Inc | VCYT | 3.00% | ![]() |
0.23 | (0.87%) |
15 | Intellia Therapeutics Inc | NTLA | 2.88% | ![]() |
0.79 | (7.15%) |
16 | Illumina Inc | ILMN | 2.54% | ![]() |
-1.36 | (-1.37%) |
17 | Absci Corp | ABSI | 2.39% | ![]() |
0.10 | (3.98%) |
18 | Arcturus Therapeutics Holdin | ARCT | 2.19% | ![]() |
0.67 | (4.88%) |
19 | Nurix Therapeutics Inc | NRIX | 1.85% | ![]() |
0.47 | (3.85%) |
20 | Amgen Inc | AMGN | 1.62% | ![]() |
0.59 | (0.20%) |
21 | Pacific Biosciences of Calif | PACB | 1.58% | ![]() |
-0.05 | (-3.67%) |
22 | 908 Devices Inc | MASS | 1.43% | ![]() |
0.14 | (1.98%) |
23 | Quantum-Si Inc | QSI | 1.39% | ![]() |
0.00 | (0.28%) |
24 | Veeva Systems Inc-Class A | VEEV | 1.34% | ![]() |
1.55 | (0.55%) |
25 | Butterfly Network Inc | BFLY | 1.15% | ![]() |
-0.00 | (-0.26%) |
26 | Vertex Pharmaceuticals Inc | VRTX | 1.05% | ![]() |
7.40 | (1.59%) |
27 | Incyte Corp | INCY | 0.99% | ![]() |
0.59 | (0.88%) |
28 | Cerus Corp | CERS | 0.96% | ![]() |
0.02 | (1.37%) |
29 | Prime Medicine Inc | PRME | 0.84% | ![]() |
0.49 | (11.93%) |
30 | Regeneron Pharmaceuticals | REGN | 0.65% | ![]() |
3.39 | (0.62%) |
31 | Compass Pathways Plc | CMPS | 0.62% | ![]() |
0.13 | (3.61%) |
32 | Standard Biotools Inc | LAB | 0.39% | ![]() |
0.02 | (1.92%) |
33 | Atai Life Sciences Nv | ATAI | 0.26% | ![]() |
0.02 | (0.57%) |
34 | Goldman Fs Trsy Oblig Inst 468 | 0.16% | ![]() |
0.00 | (0.00%) | |
35 | Caris Life Sciences Inc | CAI | 0.12% | ![]() |
0.01 | (0.04%) |
ARKK | ![]() |
0.90 | (1.27%) |
ARKQ | ![]() |
0.23 | (0.26%) |
ARKW | ![]() |
1.51 | (1.02%) |
ARKG | ![]() |
0.61 | (2.43%) |
ARKF | ![]() |
0.46 | (0.92%) |
ARKX | ![]() |
0.02 | (0.06%) |
PRNT | ![]() |
0.11 | (0.50%) |
IZRL | ![]() |
0.42 | (1.51%) |
The holdings for the ARK Genomic Revolution ETF are updated after each trading day. Exact holdings and weights are subject to change daily. There are currently 35 holdings in the fund.
Data as of 07/08/2025.